Paragraph IV Certifications: How Generic Drug Companies Challenge Patents Before Launch
Paragraph IV certifications let generic drug makers challenge brand patents before launch, speeding up affordable medicine. Learn how the Hatch-Waxman Act enables this legal battle - and why it saves patients billions.
Read More